Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00508339
Collaborator
(none)
0
1
13
0

Study Details

Study Description

Brief Summary

Primary Objectives:
  1. To classify the types of wound healing complications that occur after pre-operative radiation therapy and limb sparing resection for the treatment of soft tissue sarcomas of the extremity.

  2. To evaluate the impact of each complication type on patient function and quality of life using the Toronto Extremity Salvage Score (TESS).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Questionnaire

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Functional Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma and Pre-Operative Radiotherapy
Study Start Date :
Sep 1, 2006
Actual Primary Completion Date :
Oct 1, 2007
Actual Study Completion Date :
Oct 1, 2007

Arms and Interventions

Arm Intervention/Treatment
1

Patients with a diagnosis of soft tissue sarcoma.

Behavioral: Questionnaire
Toronto Extremity Salvage Score (TESS) questionnaire.
Other Names:
  • Survey
  • Outcome Measures

    Primary Outcome Measures

    1. Endpoints for this study will be anatomic site, histological subtype, primary wound closure, wound complication type, need for secondary operation and type of secondary operation. [1 Year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Diagnosis of soft tissue sarcoma with histopathologic confirmation.

    2. Treatment protocol that includes pre-operative radiation therapy.

    3. Treatment protocol that includes limb-sparing surgical resection.

    4. Patient has received MD Anderson Cancer Center multidisciplinary care.

    5. Patient must be at least three years post-operative.

    Exclusion Criteria:
    1. Previous radiotherapy to the local site.

    2. Presence of regional or distant metastases.

    3. Major medical co-morbidities (eg. cerebrovascular accident, congestive heart failure, concurrent malignancy) or disabilities unrelated to treatment for soft tissue sarcoma.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 U.T.M.D. Anderson Cancer Center Houston Texas United States 77030

    Sponsors and Collaborators

    • M.D. Anderson Cancer Center

    Investigators

    • Principal Investigator: Charles E. Butler, MD, M.D. Anderson Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    M.D. Anderson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT00508339
    Other Study ID Numbers:
    • 2005-0111
    First Posted:
    Jul 27, 2007
    Last Update Posted:
    Aug 1, 2012
    Last Verified:
    Jul 1, 2012
    Keywords provided by M.D. Anderson Cancer Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 1, 2012